GOLDMAN SACHS GROUP INC - ROCK CREEK PHARMACEUTICALS I ownership

ROCK CREEK PHARMACEUTICALS I's ticker is RCPI and the CUSIP is 772081105. A total of 56 filers reported holding ROCK CREEK PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ROCK CREEK PHARMACEUTICALS I
ValueSharesWeighting
Q1 2015$36,000
-43.8%
350,457
-0.7%
0.00%
Q4 2014$64,000
-49.6%
352,897
-22.0%
0.00%
Q3 2014$127,000
-30.2%
452,195
+46.6%
0.00%
Q2 2014$182,000308,4250.00%
Other shareholders
ROCK CREEK PHARMACEUTICALS I shareholders Q1 2015
NameSharesValueWeighting ↓
GOLDMAN CAPITAL MANAGEMENT INC 5,485,500$1,536,0000.77%
Talkot Capital, LLC 2,097,922$738,0000.26%
KEMPNER CAPITAL MANAGEMENT INC. 240,000$67,0000.03%
PARSONS CAPITAL MANAGEMENT INC/RI 157,100$44,0000.01%
Financial Sense Advisors, Inc. 33,000$9,0000.00%
BRAVE ASSET MANAGEMENT INC 15,000$4,0000.00%
Somerset Group LLC 10,000$3,0000.00%
LUCAS CAPITAL MANAGEMENT 38,900$11,0000.00%
THOMPSON DAVIS & CO., INC. 2,000$1,0000.00%
Formidable Asset Management, LLC 2,000$1,0000.00%
View complete list of ROCK CREEK PHARMACEUTICALS I shareholders